Archives of Medicine

contact@imedpub.com Submit a Manuscript

Intramuscular Interferon

Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS). It is produced in mammalian cells, while interferon beta-1b is produced in E. transformed coli. Other claims have been made that Interferons produces about 18-38% decrease in MS return rate. Interferon beta has not been shown to further impair disability. Interferons are not a cure for MS (no known cure); the claim is that interferons may slow the progression of the disease if it begins early and prolongs the disease. The drug works modestly in reducing the number of attacks in multiple-sclerosis and reducing the saturation of brain lesions, measured using gadolinium-activated magnetic resonance imaging (MRI). Interferons reduce the backlog by about 30% and his secure profile enables them to recover first.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Awards Nomination 17+ Million Readerbase
Google Scholar citation report
Citations : 499

Archives of Medicine received 499 citations as per Google Scholar report

image
Archives of Medicine peer review process verified at publons
image
Abstracted/Indexed in
  • Google Scholar
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Proquest Summons
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Secret Search Engine Labs
  • Euro Pub

View More »

Open Access Journals